Immunotherapy and Behavioural Immunity
Behavioural immunity that allow individual organisms to detect the possible presence of disease-causing parasites in their instant environment, and to seize in behaviours which prevent contact with those objects and individuals. The treatment using components of the immune system or antigens for immune disorders is called immunotherapy. Immunotherapy can activate or supress the immune system. Immunotherapies that activate the immune response are called activation immunotherapies. Immunotherapies that suppress the immune system are called suppression immunotherapies.
Immunotherapy is mainly used to treat:
- Allergies
- Autoimmune disorders
- Cancers
Related Conference of Immunotherapy and Behavioural Immunity
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Immunotherapy and Behavioural Immunity Conference Speakers
Recommended Sessions
- Immune Disorders
- Allergic Contact Dermatitis
- Allergic Rhinitis
- Allergy and Inflammation
- Anaphylaxis and Asthma
- Autoimmune Diseases
- Cancer Immunology
- Clinical Immunology
- Coronavirus and SARS-CoV-2
- Developmental Immunology
- Food Allergy and Drug Allergy
- Immune System and Allergic Reactions
- Immunopathology of COVID 19
- Immunotherapy and Behavioural Immunity
- Market and Future of Therapeutics
- Molecular Allergology and Allergy Diagnostics
- Neonatal and Pediatric Immunology
- Oral Allergy Syndrome
- Oral Immunotherapy and Allergen Immunotherapy
- Vaccination and Immunisation
- Veterinary Allergology
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)